• slideshow1
  • slideshow1
  • slideshow1
  • slideshow1

Fab’entech is a French biopharmaceutical SME developing immunotherapies to address situations of medical emergency.

Based on a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech develops therapeutic solutions to address bioterrorism threats & emerging infectious diseases, but also intoxications and recurrent infectious diseases.

Fab’entech is currently seeking partners to initiate the development of emergency immunotherapies in additional indications, as well as investors to close a Series B fundraising by Q4 2017.

Partners

...  Read more

  • Last news
  • Last tweets
  • [rotatingtweets screen_name='Fabentech']